INTEGRATED BIOPHARMA INC (INBP)
INBP moved a median of 0.00% 30 minutes after news, and +1.68% by the close. How INBP actually reacts to news — the realized, point-in-time move the market made, measured across 86 labeled events over the last three years with zero look-ahead.
INBP’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 30% | 33 |
| 30-min | 0.00% | 45% | 40 |
| 60-min | 0.00% | 48% | 40 |
| to close | +1.68% | 52% | 56 |
| Middle 50% of INBP reactions | 0.00% to +5.23% |
|---|---|
| Median reaction (30-min) | 0.00% |
| Measured reactions | 86 |
Half of all INTEGRATED BIOPHARMA INC news events land between +0.00% and +5.23% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
Email me when INBP moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to INBP's baseline. Nothing else.
Recent INBP events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Form 10-K INTEGRATED BIOPHARMA For: Jun 30 | SEC filing · Form 10-K | SEC EDGAR | -0.66% | -6.75% | |
| Form 8-K INTEGRATED BIOPHARMA For: Sep 25 | SEC filing · Form 8-K | SEC EDGAR | -0.66% | -6.75% | |
| Integrated BioPharma Reports Results for its Quarter and Fiscal Year Ended June 30, 2026 | Press release | ACCESS Newswire | -0.66% | -6.75% | |
| Form 8-K INTEGRATED BIOPHARMA For: Aug 20 | SEC filing · Form 8-K | SEC EDGAR | — | — | |
| Form 8-K INTEGRATED BIOPHARMA For: Jun 30 | SEC filing · Form 8-K | SEC EDGAR | — | — | |
| Form 10-Q INTEGRATED BIOPHARMA For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | — | — | |
| Form 8-K INTEGRATED BIOPHARMA For: May 08 | SEC filing · Form 8-K | SEC EDGAR | — | — | |
| Integrated BioPharma Reports Results for its Quarter Ended March 31, 2026 | Press release | ACCESS Newswire | — | — | |
| Form 8-K INTEGRATED BIOPHARMA For: Apr 14 | SEC filing · Form 8-K | SEC EDGAR | — | +0.00% | |
| Form 8-K INTEGRATED BIOPHARMA For: Feb 17 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -2.46% | |
| Form 10-Q INTEGRATED BIOPHARMA For: Dec 31 | SEC filing · Form 10-Q | SEC EDGAR | +2.14% | +10.68% | |
| Form 8-K INTEGRATED BIOPHARMA For: Feb 11 | SEC filing · Form 8-K | SEC EDGAR | +2.14% | +10.68% | |
| Integrated BioPharma Reports Results for Its Quarter Ended December 31, 2025 | Press release | ACCESS Newswire | +2.14% | +10.68% | |
| Form 10-Q INTEGRATED BIOPHARMA For: Sep 30 | SEC filing · Form 10-Q | SEC EDGAR | — | +0.00% | |
| Form 8-K INTEGRATED BIOPHARMA For: Nov 10 | SEC filing · Form 8-K | SEC EDGAR | — | +0.00% | |
| Integrated BioPharma Reports Results for Its Quarter Ended September 30, 2025 | Press release | ACCESS Newswire | — | +0.00% | |
| Form DEF 14A INTEGRATED BIOPHARMA For: Oct 28 | SEC filing · Form DEF | SEC EDGAR | — | — | |
| Form 10-K INTEGRATED BIOPHARMA For: Jun 30 | SEC filing · Form 10-K | SEC EDGAR | — | +17.86% | |
| Form 8-K INTEGRATED BIOPHARMA For: Sep 23 | SEC filing · Form 8-K | SEC EDGAR | — | +10.52% | |
| Integrated BioPharma Reports Results for its Quarter and Fiscal Year Ended June 30, 2025 | Press release | ACCESS Newswire | — | +10.52% | |
| Form 10-Q INTEGRATED BIOPHARMA For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | +4.17% | +3.91% | |
| Form 8-K INTEGRATED BIOPHARMA For: May 14 | SEC filing · Form 8-K | SEC EDGAR | — | -0.24% | |
| Integrated BioPharma Reports Results for its Quarter Ended March 31, 2025 | Press release | ACCESS Newswire | +3.57% | +3.32% | |
| Form 8-K INTEGRATED BIOPHARMA For: Apr 24 | SEC filing · Form 8-K | SEC EDGAR | — | — | |
| Form 8-K INTEGRATED BIOPHARMA For: Apr 15 | SEC filing · Form 8-K | SEC EDGAR | — | +0.00% | |
| Form 8-K INTEGRATED BIOPHARMA For: Feb 13 | SEC filing · Form 8-K | SEC EDGAR | -5.96% | -10.55% | |
| Integrated BioPharma Reports Results for its Quarter Ended December 31, 2024 | Press release | ACCESS Newswire | +4.76% | +4.76% | |
| Form 8-K INTEGRATED BIOPHARMA For: Dec 02 | SEC filing · Form 8-K | SEC EDGAR | — | +0.00% | |
| Form 8-K INTEGRATED BIOPHARMA For: Nov 13 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +6.00% | |
| Form 10-Q INTEGRATED BIOPHARMA For: Sep 30 | SEC filing · Form 10-Q | SEC EDGAR | -1.49% | +4.48% | |
| Integrated BioPharma Reports Results for its Quarter Ended September 30, 2024 | Press release | Accesswire | -1.49% | +4.48% | |
| Form DEF 14A INTEGRATED BIOPHARMA For: Oct 28 | SEC filing · Form DEF | SEC EDGAR | +0.00% | +0.46% | |
| Form 8-K INTEGRATED BIOPHARMA For: Sep 20 | SEC filing · Form 8-K | SEC EDGAR | — | +0.00% | |
| Form 10-K INTEGRATED BIOPHARMA For: Jun 30 | SEC filing · Form 10-K | SEC EDGAR | +0.00% | +8.65% | |
| Integrated BioPharma Reports Results for Its Quarter and Fiscal Year Ended June 30, 2024 | Press release | Accesswire | +0.00% | +8.65% | |
| Form 10-Q INTEGRATED BIOPHARMA For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | +0.00% | +20.16% | |
| Form 8-K INTEGRATED BIOPHARMA For: May 10 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +20.16% | |
| Integrated BioPharma Reports Results for its Quarter Ended March 31, 2024 | Press release | Accesswire | +0.00% | +20.16% | |
| Form 10-Q INTEGRATED BIOPHARMA For: Dec 31 | SEC filing · Form 10-Q | SEC EDGAR | +0.00% | -4.76% | |
| Form 8-K INTEGRATED BIOPHARMA For: Feb 12 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -4.76% | |
| Integrated BioPharma Reports Results for its Quarter Ended December 31, 2023 | Press release | Accesswire | +0.00% | -4.76% | |
| Form 8-K INTEGRATED BIOPHARMA For: Nov 27 | SEC filing · Form 8-K | SEC EDGAR | — | +0.00% | |
| Form 10-Q INTEGRATED BIOPHARMA For: Sep 30 | SEC filing · Form 10-Q | SEC EDGAR | +0.00% | +17.39% | |
| Form 8-K INTEGRATED BIOPHARMA For: Nov 09 | SEC filing · Form 8-K | SEC EDGAR | — | +0.00% | |
| Integrated BioPharma Reports Results for its Quarter Ended September 30, 2023 | Press release | Accesswire | — | +17.39% | |
| Form DEF 14A INTEGRATED BIOPHARMA For: Oct 27 | SEC filing · Form DEF | SEC EDGAR | — | — |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the INBP section they belong to.
Where else INBP is measured.
INBP earnings → · Analyst actions → · SEC filings →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Flurotech Ltd (TEST_CDNX) | 87 | 0.00% | 41% |
| Agile Therapeutics, Inc. (AGRX) | 86 | 0.00% | 41% |
| NORTHWEST BIOTHRPUTCS INC (NWBO) | 86 | -0.49% | 41% |
| SWEDISH ORPHAN ADR (SWTUY) | 86 | 0.00% | 8% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.
All Healthcare names, measured the same way →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is INTEGRATED BIOPHARMA INC's median reaction calculated?
Every labeled INBP news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 86 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 45% of INBP's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does INBP's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.